These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18992256)

  • 41. The molecular basis for substrate specificity of the nuclear NIPP1:PP1 holoenzyme.
    O'Connell N; Nichols SR; Heroes E; Beullens M; Bollen M; Peti W; Page R
    Structure; 2012 Oct; 20(10):1746-56. PubMed ID: 22940584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
    Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?
    Honkanen RE; Golden T
    Curr Med Chem; 2002 Nov; 9(22):2055-75. PubMed ID: 12369870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between ATM and ribosomal protein S6 revealed by the chemical inhibition of Ser/Thr protein phosphatase type 1.
    Li Y; Mitsuhashi S; Ikejo M; Miura N; Kawamura T; Hamakubo T; Ubukata M
    Biosci Biotechnol Biochem; 2012; 76(3):486-94. PubMed ID: 22451389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How phosphorylation activates the protein phosphatase-1 • inhibitor-2 complex.
    Cannon JF
    Biochim Biophys Acta; 2013 Jan; 1834(1):71-86. PubMed ID: 22982244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.
    Endo S; Zhou X; Connor J; Wang B; Shenolikar S
    Biochemistry; 1996 Apr; 35(16):5220-8. PubMed ID: 8611507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of [18,19,21,22-(13)C4]-labeled tautomycin as an NMR probe of protein phosphatase inhibitor.
    Isobe M; Kurono M; Tsuboi K; Takai A
    Chem Asian J; 2007 Mar; 2(3):377-85. PubMed ID: 17441173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate.
    Egloff MP; Cohen PT; Reinemer P; Barford D
    J Mol Biol; 1995 Dec; 254(5):942-59. PubMed ID: 7500362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corozalic acid: a key okadaic acid biosynthetic precursor with phosphatase inhibition activity.
    Napolitano JG; Norte M; Fernández JJ; Hernández Daranas A
    Chemistry; 2010 Oct; 16(38):11576-9. PubMed ID: 20803584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
    Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
    J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of stably incorporated iron on protein phosphatase-1 structure and activity.
    Salvi F; Trebacz M; Kokot T; Hoermann B; Rios P; Barabas O; Köhn M
    FEBS Lett; 2018 Dec; 592(24):4028-4038. PubMed ID: 30403291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity.
    Ju J; Li W; Yuan Q; Peters NR; Hoffmann FM; Rajski SR; Osada H; Shen B
    Org Lett; 2009 Apr; 11(7):1639-42. PubMed ID: 19281218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-activity relationship within a series of degradation products of tautomycin.
    Nishiyama U; Ubukata M; Magae J; Kataoka T; Erdödi F; Hartshorne DJ; Isono K; Nagai K; Osada H
    Biosci Biotechnol Biochem; 1996 Jan; 60(1):103-7. PubMed ID: 8824829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
    Fujiki H; Suganuma M
    Prog Mol Subcell Biol; 2009; 46():221-54. PubMed ID: 19184590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.
    Liu JY; Chen XE; Zhang YL
    Sci Rep; 2015 Jul; 5():12359. PubMed ID: 26190207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biogenesis and activity regulation of protein phosphatase 1.
    Verbinnen I; Ferreira M; Bollen M
    Biochem Soc Trans; 2017 Feb; 45(1):89-99. PubMed ID: 28202662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for protein phosphatase 1 regulation and specificity.
    Peti W; Nairn AC; Page R
    FEBS J; 2013 Jan; 280(2):596-611. PubMed ID: 22284538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disruption of protein phosphatase 1 complexes with the use of bioportides as a novel approach to target sperm motility.
    Silva JV; Freitas MJ; Santiago J; Jones S; Guimarães S; Vijayaraghavan S; Publicover S; Colombo G; Howl J; Fardilha M
    Fertil Steril; 2021 Feb; 115(2):348-362. PubMed ID: 32977940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1.
    Connor JH; Weiser DC; Li S; Hallenbeck JM; Shenolikar S
    Mol Cell Biol; 2001 Oct; 21(20):6841-50. PubMed ID: 11564868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a regulatory subunit of protein phosphatase 1 which mediates blue light signaling for stomatal opening.
    Takemiya A; Yamauchi S; Yano T; Ariyoshi C; Shimazaki K
    Plant Cell Physiol; 2013 Jan; 54(1):24-35. PubMed ID: 22585556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.